Skip navigation

COMESA

Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:

  • The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
  • The value added resulting from the process of production accounts for at least 35% of the ex-factory cost of the goods;
  • Manufacture from materials classified in a heading other than that of the product

EAC

Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:

  • The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
  • The value added resulting from the process of production accounts for at least 35% of the ex-factory cost of the goods;
  • Manufacture from materials classified within a heading other than that of the product - Manufacture from any other heading is recognized as a substantial process.

EU GSP

Exception: Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale, of heading 3002

Applies to: 300210, 300220, 300230 and 300290
Exception: Human blood of heading 3002

Applies to: 300210, 300220, 300230 and 300290
Exception: Animal blood, prepared for therapeutic or prophylactic uses, of heading 3002

Applies to: 300210, 300220, 300230 and 300290
Exception: Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins, of heading 3002

Applies to: 300210, 300220, 300230 and 300290
Exception: Haemoglobin, blood globulins and serum globulins, of heading 3002

Applies to: 300210, 300220, 300230 and 300290
Exception: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of mic

Applies to: 300210, 300220, 300230 and 300290